Visión generalGráficoNoticiasTraderScreen

DZ Bank Discount Zert SAX 27.09.2.../  DE000DJ2PVD9  /

EUWAX
27/06/2024  8:19:31 Diferencia-0.03 Bid9:15:11 Ask9:15:11 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
29.65EUR -0.10% 29.69
Volumen de oferta: 10,000		 29.74
Tamaño/ Volumen/ Formato de Ask: 10,000		 STROEER SE + CO. KGA... - - 27/09/2024 Call
TeleTrader 12:47 US embassy warns against travel to Lebanon
GlobeNewswire 12:40 Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER Wa...
GlobeNewswire 12:30 Oculis and EURETINA Announces the Ramin Tadayoni Award
GlobeNewswire 12:30 Hut 8 Set to Join to Russell 3000® Index
GlobeNewswire 12:30 X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of ...
GlobeNewswire 12:30 Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
TeleTrader 12:29 China's Communist Party expels former defense minister
TeleTrader 12:20 Ryabkov: Russia expands talks with allies on military coop
TeleTrader 12:16 Palestinian GDP contracts 35% in Q1, local bureau says
GlobeNewswire 12:15 H World Group Limited Announces Voting Results of 2024 Annual General Meeting
TeleTrader 12:01 Two candidates quit presidential race ahead of Iranian elections
GlobeNewswire 12:00 Global Net Lease Sells Americold Portfolio for $170 Million
GlobeNewswire 12:00 Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Inte...
GlobeNewswire 12:00 Nightfood Holdings Inc. New Subsidiary, Future Hospitality Ventures, Solves Hospitality Labor Crisis
GlobeNewswire 12:00 Action1 Achieves CSA STAR Level 1 Certification and Signs CISA's Secure by Design Pledge
GlobeNewswire 12:00 Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Ann...
GlobeNewswire 12:00 FUTUREFUEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed A...
GlobeNewswire 12:00 GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a ...
GlobeNewswire 12:00 Interlock Launches ThreatSlayer Web3 Security Extension and Incentivized Crowdsourced Internet Secur...
GlobeNewswire 12:00 Acuity Brands Reports Fiscal 2024 Third-Quarter Results
GlobeNewswire 12:00 LanzaTech and LanzaJet Introduce CirculAir™, a Revolutionary and Commercially Ready Solution to Conv...
GlobeNewswire 11:56 Cost of new drug development is key concern for life science as focus shifts to repurposing
TeleTrader 11:43 BoE: Risk environment broadly unchanged in Q2
TeleTrader 11:42 Shooting leaves two dead, three wounded in Brussels
TeleTrader 11:28 Ship struck in Red Sea, suspected Houthi attack